|
|
Name: |
Soleus Capital Management L.P. |
City: |
GREENWICH |
State: |
CT |
Zip: |
06830 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
100 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
UTHR |
United Therapeutics Corp |
1 |
- |
$272.88 |
$59,670,000 |
259,749 |
5.24% |
4,819,000 |
10,300 |
0.55 |
Drug Manufacturers - ... |
|
EDAP |
EDAP TMS S.A. (ADR) |
2 |
- |
$6.12 |
$53,121,000 |
7,227,353 |
4.67% |
14,966,000 |
1,012 |
24.802 |
Medical Appliances & ... |
|
IOVA |
Iovance Biotherapeutics Inc |
3 |
- |
$10.01 |
$51,944,000 |
3,505,000 |
4.56% |
47,432,000 |
2,950,000 |
1.639 |
N/A |
|
TEVA |
Teva Pharmaceutical Industr... |
4 |
- |
$16.60 |
$49,194,000 |
3,486,440 |
4.32% |
-8,899,000 |
-2,078,000 |
0.318 |
Drug Manufacturers - ... |
|
TGTX |
TG Therapeutics Inc |
5 |
- |
$16.71 |
$48,192,000 |
3,168,456 |
4.23% |
37,090,000 |
2,518,456 |
2.458 |
Drug Manufacturers - ... |
|
CELC |
Celcuity Inc. |
6 |
- |
$15.64 |
$37,397,000 |
1,731,338 |
3.28% |
5,642,000 |
-448,143 |
7.99 |
N/A |
|
JSPR |
Jasper Therapeutics Ord Shs |
7 |
- |
$15.12 |
$34,853,000 |
1,187,096 |
3.06% |
27,065,000 |
-8,683,884 |
1.169 |
N/A |
|
NPCE |
Neuropace Inc |
8 |
- |
$7.53 |
$32,118,000 |
2,433,168 |
2.82% |
7,032,000 |
0 |
10.017 |
N/A |
|
EPIX |
ESSA Pharma Inc |
9 |
- |
$0.00 |
$30,475,000 |
3,589,558 |
2.68% |
1,913,000 |
-738,064 |
8.162 |
Diagnostic Substances |
|
ORGO |
Organogenesis Holdings Inc |
10 |
- |
$2.63 |
$27,188,000 |
9,573,198 |
2.39% |
-9,471,000 |
610,198 |
7.497 |
N/A |
|
AXGN |
Axogen Inc |
11 |
- |
$6.27 |
$25,064,000 |
3,105,815 |
2.2% |
7,335,000 |
510,000 |
7.473 |
Medical Appliances & ... |
|
HUM |
Humana Inc |
12 |
- |
$349.30 |
$24,966,000 |
72,006 |
2.19% |
-8,777,000 |
-1,700 |
0.054 |
Health Care Plans |
|
SRDX |
Surmodics Inc |
13 |
- |
$34.38 |
$23,496,000 |
800,820 |
2.06% |
-4,555,000 |
29,120 |
5.774 |
Specialty Chemicals |
|
RVMD |
Revolution Medicines, Inc. |
14 |
- |
$37.95 |
$23,486,000 |
728,700 |
2.06% |
16,259,000 |
476,700 |
0.445 |
N/A |
|
IDYA |
Ideaya Biosciences, Inc. |
15 |
- |
$0.00 |
$23,411,000 |
533,515 |
2.06% |
3,319,000 |
-31,185 |
0.74 |
N/A |
|
BGNE |
Beigene Ltd |
16 |
New |
$152.71 |
$23,161,000 |
148,100 |
2.03% |
23,161,000 |
148,100 |
0.163 |
N/A |
|
CCCC |
C4 Therapeutics, Inc. |
17 |
- |
$0.00 |
$20,090,000 |
2,458,996 |
1.76% |
9,717,000 |
623,000 |
4.99 |
N/A |
|
PEN |
Penumbra Inc |
18 |
- |
$193.66 |
$19,127,000 |
85,700 |
1.68% |
-845,000 |
6,300 |
0.236 |
N/A |
|
VSTM |
Verastem, Inc. |
19 |
- |
$4.12 |
$18,179,000 |
1,540,634 |
1.6% |
6,574,000 |
115,000 |
6.106 |
Biotechnology |
|
KROS |
Keros Therapeutics, Inc. |
20 |
- |
$0.00 |
$18,112,000 |
273,600 |
1.59% |
18,112,000 |
273,600 |
0.805 |
N/A |
|
TMCI |
Treace Medical Concepts, Inc. |
21 |
- |
$5.16 |
$17,561,000 |
1,345,648 |
1.54% |
4,632,000 |
331,643 |
2.551 |
N/A |
|
HCA |
HCA Holdings Inc |
22 |
- |
$318.70 |
$17,157,000 |
51,441 |
1.51% |
-10,317,000 |
-50,059 |
0.015 |
Hospitals |
|
NRIX |
Nurix Therapeutics, Inc. |
23 |
- |
$0.00 |
$16,391,000 |
1,115,000 |
1.44% |
14,915,000 |
972,000 |
2.37 |
N/A |
|
CSTL |
Castle Biosciences Inc |
24 |
- |
$0.00 |
$16,069,000 |
725,457 |
1.41% |
15,508,000 |
699,457 |
2.93 |
N/A |
|
IRMD |
Iradimed Corp |
25 |
- |
$0.00 |
$15,908,000 |
361,630 |
1.4% |
-14,625,000 |
-281,576 |
2.947 |
N/A |
|
BIIB |
Biogen Idec Inc |
26 |
New |
$217.81 |
$15,698,000 |
72,800 |
1.38% |
15,698,000 |
72,800 |
0.047 |
Biotechnology |
|
KRYS |
Krystal Biotech Inc |
27 |
- |
$162.83 |
$14,964,000 |
84,100 |
1.31% |
10,002,000 |
44,100 |
0.338 |
N/A |
|
PCVX |
Vaxcyte, Inc. |
28 |
- |
$0.00 |
$14,191,000 |
207,750 |
1.25% |
-11,899,000 |
-207,700 |
0.193 |
N/A |
|
BCAB |
Bioatla, Inc. |
29 |
- |
$0.00 |
$13,984,000 |
4,065,197 |
1.23% |
3,984,000 |
0 |
8.816 |
N/A |
|
GSK |
GlaxoSmithKline Plc (ADR) |
30 |
- |
$40.41 |
$13,685,000 |
319,217 |
1.2% |
-33,698,000 |
-959,323 |
0.016 |
Drug Manufacturers - ... |
|
RIGL |
Rigel Pharmaceuticals Inc |
31 |
- |
$1.22 |
$13,678,000 |
9,241,986 |
1.2% |
-14,000 |
-200,593 |
5.469 |
Drug Manufacturers - ... |
|
ENGN |
Engene Holdings Inc. |
32 |
New |
$12.86 |
$13,560,000 |
800,000 |
1.19% |
13,560,000 |
800,000 |
3.448 |
N/A |
|
NARI |
Inari Medical, Inc. |
33 |
New |
$0.00 |
$13,290,000 |
277,000 |
1.17% |
13,290,000 |
277,000 |
0.536 |
N/A |
|
NVCR |
Novocure Ltd |
34 |
- |
$23.15 |
$10,875,000 |
695,759 |
0.96% |
6,381,000 |
394,759 |
0.683 |
N/A |
|
TNGX |
Tango Therapeutics Ord Shs |
35 |
- |
$0.00 |
$10,720,000 |
1,350,145 |
0.94% |
2,333,000 |
503,000 |
1.324 |
N/A |
|
APLT |
Applied Therapeutics Inc. |
36 |
- |
$0.00 |
$10,641,000 |
1,564,916 |
0.93% |
9,097,000 |
1,104,123 |
2.026 |
N/A |
|
ACLX |
Arcellx, Inc. |
37 |
- |
$0.00 |
$10,433,000 |
150,000 |
0.92% |
1,608,000 |
-9,000 |
0.306 |
N/A |
|
ENTA |
Enanta Pharmaceuticals Inc |
38 |
New |
$12.03 |
$10,136,000 |
580,546 |
0.89% |
10,136,000 |
580,546 |
2.893 |
Biotechnology |
|
NUVL |
Nuvalent, Inc. |
39 |
- |
$0.00 |
$9,708,000 |
129,288 |
0.85% |
-14,053,000 |
-193,600 |
0.197 |
N/A |
|
IMUX |
Immunic Inc |
40 |
- |
$1.25 |
$9,627,000 |
7,293,007 |
0.85% |
9,177,000 |
6,993,007 |
16.441 |
N/A |
|
CGON |
CG Oncology, Inc |
41 |
New |
$32.71 |
$9,565,000 |
217,871 |
0.84% |
9,565,000 |
217,871 |
0.33 |
N/A |
|
INBX |
Inhibrx, Inc. |
42 |
- |
$0.00 |
$9,365,000 |
267,871 |
0.82% |
8,795,000 |
252,871 |
0.565 |
N/A |
|
PHVS |
Pharvaris N V Ord Shs |
43 |
- |
$0.00 |
$9,288,000 |
401,901 |
0.82% |
3,190,000 |
184,505 |
0.97 |
N/A |
|
YMAB |
Y-Mabs Therapeutics Inc |
44 |
- |
$12.22 |
$9,284,000 |
570,982 |
0.82% |
8,212,000 |
413,800 |
1.427 |
N/A |
|
MRUS |
Merus Nv |
45 |
- |
$59.99 |
$8,807,000 |
195,577 |
0.77% |
486,000 |
-107,000 |
0.339 |
N/A |
|
SNDX |
Syndax Pharmaceuticals Inc |
46 |
- |
$20.28 |
$8,782,000 |
369,000 |
0.77% |
-2,326,000 |
-145,000 |
0.392 |
N/A |
|
MREO |
Mereo Biopharma Group plc |
47 |
- |
$2.95 |
$8,636,000 |
2,616,953 |
0.76% |
-13,950,000 |
-7,160,466 |
2.418 |
N/A |
|
IMVT |
Immunovant Inc |
48 |
- |
$0.00 |
$8,551,000 |
264,650 |
0.75% |
-4,806,000 |
-52,400 |
0.304 |
N/A |
|
THTX |
Theratechnologies Ord Shs |
49 |
- |
$0.00 |
$7,970,000 |
4,801,376 |
0.7% |
192,000 |
0 |
19.832 |
N/A |
|
NTRA |
Natera, Inc. |
50 |
- |
$109.51 |
$7,957,000 |
87,000 |
0.7% |
7,957,000 |
87,000 |
0.076 |
N/A |
|
OLMA |
Olema Pharmaceuticals, Inc. |
51 |
New |
$0.00 |
$7,449,000 |
658,000 |
0.65% |
7,449,000 |
658,000 |
1.194 |
N/A |
|
WGS |
GeneDx Holdings Corp |
52 |
- |
$20.60 |
$7,152,000 |
783,376 |
0.63% |
6,987,000 |
723,376 |
3.061 |
N/A |
|
BHC |
Bausch Health Companies Inc |
53 |
- |
$6.36 |
$7,109,000 |
670,000 |
0.62% |
7,109,000 |
670,000 |
0.189 |
Biotechnology |
|
MNKD |
MannKind Corp |
54 |
New |
$4.78 |
$7,060,000 |
1,558,537 |
0.62% |
7,060,000 |
1,558,537 |
0.67 |
Biotechnology |
|
MNMD |
Mind Medicine |
55 |
New |
$8.23 |
$7,052,000 |
750,237 |
0.62% |
7,052,000 |
750,237 |
2.112 |
N/A |
|
INSM |
Insmed Inc |
56 |
- |
$22.00 |
$6,783,000 |
250,000 |
0.6% |
1,605,000 |
82,900 |
0.165 |
Biotechnology |
|
FATE |
Fate Therapeutics Inc |
57 |
New |
$3.52 |
$6,386,000 |
870,000 |
0.56% |
6,386,000 |
870,000 |
0.734 |
Biotechnology |
|
XFOR |
X4 Pharmaceuticals Inc |
58 |
New |
$0.90 |
$6,366,000 |
4,579,926 |
0.56% |
6,366,000 |
4,579,926 |
2.738 |
N/A |
|
FDMT |
4d Molecular Therapeutics Inc. |
59 |
- |
$0.00 |
$6,280,000 |
197,098 |
0.55% |
5,353,000 |
151,350 |
0.399 |
N/A |
|
VRDN |
Viridian Therapeutics Ors Shs |
60 |
- |
$12.11 |
$5,953,000 |
340,000 |
0.52% |
2,947,000 |
202,000 |
0.542 |
N/A |
|
JANX |
Janux Therapeutics, Inc. |
61 |
New |
$0.00 |
$5,941,000 |
157,800 |
0.52% |
5,941,000 |
157,800 |
0.395 |
N/A |
|
ORIC |
Oric Pharmaceuticals, Inc. |
62 |
New |
$0.00 |
$5,789,000 |
421,000 |
0.51% |
5,789,000 |
421,000 |
0.628 |
N/A |
|
VKTX |
Viking Therapeutics, Inc. |
63 |
- |
$62.75 |
$5,504,000 |
67,121 |
0.48% |
-2,614,000 |
-369,079 |
0.067 |
N/A |
|
CMPS |
Compass Pathways Plc |
64 |
- |
$0.00 |
$4,705,000 |
565,550 |
0.41% |
-3,735,000 |
-399,000 |
1.625 |
N/A |
|
KALV |
Kalvista Pharmaceuticals Inc |
65 |
New |
$11.30 |
$4,578,000 |
386,000 |
0.4% |
4,578,000 |
386,000 |
1.015 |
N/A |
|
RGLS |
Regulus Therapeutics Inc. |
66 |
New |
$2.02 |
$4,500,000 |
1,562,500 |
0.4% |
4,500,000 |
1,562,500 |
1.07 |
Biotechnology |
|
BCYC |
Bicycle Therapeutics Ltd |
67 |
- |
$0.00 |
$3,810,000 |
153,000 |
0.33% |
2,092,000 |
58,000 |
0.406 |
N/A |
|
NSPR |
Inspiremd, Inc |
68 |
- |
$0.00 |
$3,266,000 |
1,378,128 |
0.29% |
-607,000 |
0 |
6.395 |
N/A |
|
CALC |
Calcimedica Ord Shs |
69 |
New |
$0.44 |
$3,261,000 |
783,904 |
0.29% |
3,261,000 |
783,904 |
13.85 |
N/A |
|
NKTX |
Nkarta, Inc. |
70 |
New |
$0.00 |
$3,243,000 |
300,000 |
0.28% |
3,243,000 |
300,000 |
0.617 |
N/A |
|
DNTH |
Dianthus Therapeutics Ord Shs |
71 |
New |
$0.70 |
$3,000,000 |
100,000 |
0.26% |
3,000,000 |
100,000 |
0.675 |
N/A |
|
CRVO |
Cervomed Ord Shs |
72 |
New |
$0.17 |
$2,950,000 |
126,614 |
0.26% |
2,950,000 |
126,614 |
2.233 |
N/A |
|
TSHA |
Taysha Gene Therapies, Inc. |
73 |
New |
$0.00 |
$2,655,000 |
925,000 |
0.23% |
2,655,000 |
925,000 |
0.495 |
N/A |
|
PRAX |
Praxis Precision Medicines,... |
74 |
- |
$0.00 |
$2,274,000 |
37,268 |
0.2% |
2,274,000 |
37,268 |
0.071 |
N/A |
|
EOLS |
Evolus Inc |
75 |
- |
$12.51 |
$2,240,000 |
160,000 |
0.2% |
2,240,000 |
160,000 |
0.277 |
N/A |
|
ARQT |
Arcutis Biotherapeutics, Inc. |
76 |
New |
$9.16 |
$2,230,000 |
225,000 |
0.2% |
2,230,000 |
225,000 |
0.211 |
N/A |
|
ANNX |
Annexon, Inc. |
77 |
- |
$0.00 |
$2,097,000 |
292,400 |
0.18% |
-243,000 |
-223,000 |
0.34 |
N/A |
|
APGE |
Apogee Therapeutics, Inc. |
78 |
- |
$48.03 |
$1,329,000 |
20,000 |
0.12% |
351,000 |
-15,000 |
0.042 |
N/A |
|
TMDX |
Transmedics Group, Inc. |
79 |
- |
$140.29 |
$1,235,000 |
16,700 |
0.11% |
-8,482,000 |
-106,412 |
0.046 |
N/A |
|
RCEL |
Avita Therapeutics Inc |
80 |
- |
$6.09 |
$1,202,000 |
75,000 |
0.11% |
173,000 |
0 |
0.347 |
N/A |
|
PTGX |
Protagonist Therapeutics, Inc |
81 |
- |
$30.41 |
$998,000 |
34,500 |
0.09% |
-905,000 |
-48,500 |
0.06 |
N/A |
|
DNLI |
Denali Therapeutics Inc. |
82 |
- |
$19.21 |
$964,000 |
47,000 |
0.08% |
-1,826,000 |
-83,000 |
0.039 |
N/A |
|
CVRX |
Cvrx, Inc. |
83 |
New |
$7.45 |
$883,000 |
48,500 |
0.08% |
883,000 |
48,500 |
0.262 |
N/A |
|
SKIN |
Beauty Health Company Class... |
84 |
- |
$2.52 |
$755,000 |
170,000 |
0.07% |
273,000 |
15,000 |
0.127 |
N/A |
|
FOLD |
Amicus Therapeutics Inc |
85 |
New |
$10.61 |
$683,000 |
57,966 |
0.06% |
683,000 |
57,966 |
0.017 |
Biotechnology |
|
TNYA |
Tenaya Therapeutics, Inc. |
86 |
New |
$0.00 |
$639,000 |
122,222 |
0.06% |
639,000 |
122,222 |
0.191 |
N/A |
|
SILK |
Silk Road Medical Inc |
87 |
- |
$21.93 |
$183,000 |
10,000 |
0.02% |
-6,406,000 |
-527,000 |
0.022 |
N/A |
|
URGN |
Urogen Pharma Ltd. |
88 |
- |
$13.24 |
$150,000 |
10,000 |
0.01% |
150,000 |
10,000 |
0.045 |
N/A |
|
LQDA |
Liquidia Technologies Inc |
89 |
- |
$12.42 |
$148,000 |
10,000 |
0.01% |
28,000 |
0 |
0.026 |
N/A |
|
XERS |
Xeris Pharmaceuticals Inc |
90 |
- |
$1.93 |
$137,000 |
62,083 |
0.01% |
-9,000 |
0 |
0.046 |
N/A |
|
ABBV |
Abbvie Inc. |
102 |
Closed |
$157.06 |
$0 |
0 |
0% |
-2,294,000 |
-14,800 |
0 |
Drug Manufacturers - ... |
|
VYNE |
VYNE Therapeutics Inc |
95 |
Closed |
$0.22 |
$0 |
0 |
0% |
-1,640,000 |
-703,868 |
0 |
N/A |
|
ADVM |
Adverum Biotechnologies, Inc |
101 |
Closed |
$7.60 |
$0 |
0 |
0% |
-320,000 |
-425,000 |
0 |
N/A |
|
XENE |
Xenon Pharmaceuticals Inc. |
94 |
Closed |
$0.00 |
$0 |
0 |
0% |
-2,671,000 |
-58,000 |
0 |
N/A |
|
ATRC |
Atricure, Inc. |
100 |
Closed |
$23.19 |
$0 |
0 |
0% |
-13,997,000 |
-392,195 |
0 |
Medical Instruments &... |
|
RYZB |
Rayzebio, Inc. |
93 |
Closed |
$62.49 |
$0 |
0 |
0% |
-46,417,000 |
-746,622 |
0 |
N/A |
|
CVS |
CVS/Caremark Corp |
99 |
Closed |
$55.54 |
$0 |
0 |
0% |
-4,698,000 |
-59,500 |
0 |
Drug Stores |
|
ILMN |
Illumina Inc |
92 |
Closed |
$106.48 |
$0 |
0 |
0% |
-738,000 |
-5,300 |
0 |
Scientific & Technica... |
|
HARP |
Harpoon Therapeutics, Inc. |
98 |
Closed |
$0.89 |
$0 |
0 |
0% |
-9,331,000 |
-820,638 |
0 |
N/A |
|
SIBN |
Si-Bone, Inc. |
91 |
Closed |
$0.00 |
$0 |
0 |
0% |
-7,175,000 |
-341,818 |
0 |
N/A |
|